. Eligibility for donanemab trial in a population-based study of cognitive aging. J Prev Alzheimers Dis. 2025 Feb 17;:100088. Epub 2025 Feb 17 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.